These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 699184)

  • 1. Distribution of cis-platin in blood.
    Manaka RC; Wolf W
    Chem Biol Interact; 1978 Sep; 22(2-3):353-8. PubMed ID: 699184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kinetics of 35S-lipoate binding in vitro by plasma proteins and formed elements of the blood].
    Rozanov AIa; Slizovskaia K
    Ukr Biokhim Zh; 1977; 49(2):45-8. PubMed ID: 325841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.
    Tokunaga Y; Nakashima M; Sasaki H; Tomiyama N; Nakashima MN; Ichikawa M; Kaminogo M; Shibata S
    Biol Pharm Bull; 2000 Dec; 23(12):1491-6. PubMed ID: 11145184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical study of the influence of the circadian rhythm of plasma protein binding on cisplatin area under the curve.
    Hecquet B; Sucche M
    J Pharmacokinet Biopharm; 1986 Feb; 14(1):79-93. PubMed ID: 3746633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative hydrolysis and plasma protein binding of cis-platin and carboplatin in human plasma in vitro.
    Sooriyaarachchi M; Narendran A; Gailer J
    Metallomics; 2011 Jan; 3(1):49-55. PubMed ID: 21135941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro binding kinetics of cisplatin to human plasma proteins is not affected by glutathione.
    Torti L; Bernareggi A; Castoldi D; Formento ML; Cesarini R; Tognella S
    Boll Chim Farm; 1997 Apr; 136(4):301-3. PubMed ID: 9281890
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro metabolism of selenite in sheep blood: factors controlling the distribution of selenium and the labelling of plasma protein.
    McMurray CH; Davidson WB
    Biochim Biophys Acta; 1979 Mar; 583(3):332-43. PubMed ID: 444566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin binding to plasma proteins and hemoglobin in cancer patients.
    Mustonen R; Hemminki K; Hietanen P; Leppälä S; Takala M
    Arch Toxicol Suppl; 1989; 13():262-4. PubMed ID: 2774942
    [No Abstract]   [Full Text] [Related]  

  • 9. [Barbamyl distribution in human blood].
    Kudrin AN; Hoang KK; Zatsepilova TA
    Farmakol Toksikol; 1985; 48(2):113-5. PubMed ID: 3996564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cholesterol in the distribution of haloperidol and trifluoperazine in blood and plasma.
    Rice E; Makuku S
    Biochem Pharmacol; 1981 May; 30(9):951-7. PubMed ID: 7236316
    [No Abstract]   [Full Text] [Related]  

  • 11. The distribution of chlorpromazine between plasma and erythrocytes.
    Lund A
    Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):300-4. PubMed ID: 7468230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time dependency in plasmatic protein binding of cisplatin.
    Hecquet B; Meynadier J; Bonneterre J; Adenis L; Demaille A
    Cancer Treat Rep; 1985 Jan; 69(1):79-83. PubMed ID: 4038472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic properties of platinium derivatives].
    Boisdron-Celle M; Lebouil A; Allain P; Gamelin E
    Bull Cancer; 2001 Aug; 88 Spec No():S14-9. PubMed ID: 11567909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological pharmacokinetic parameters for cis-dichlorodiammineplatinum(II) (DDP) in the mouse.
    King FG; Dedrick RL
    J Pharmacokinet Biopharm; 1992 Feb; 20(1):95-9. PubMed ID: 1588505
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma protein binding and blood cell distribution of propranolol enantiomers in rats.
    Takahashi H; Ogata H
    Biochem Pharmacol; 1990 May; 39(9):1495-8. PubMed ID: 2334449
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of bornaprolol to human serum proteins and blood cells.
    Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells.
    Borondy P; Dill WA; Chang T; Buchanan RA; Glazko AJ
    Ann N Y Acad Sci; 1973 Nov; 226():82-7. PubMed ID: 4520405
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.
    Vermorken JB; van der Vijgh WJ; Klein I; Hart AA; Gall HE; Pinedo HM
    Cancer Treat Rep; 1984 Mar; 68(3):505-13. PubMed ID: 6538459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the interaction of diazepam with human, rat and mouse plasma proteins and erythrocytes.
    Láznícek M; Lamka J; Kvĕtina J
    Biochem Pharmacol; 1982 Apr; 31(7):1455-8. PubMed ID: 7092935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood.
    Lemaire M; Tillement JP
    J Pharm Pharmacol; 1982 Nov; 34(11):715-8. PubMed ID: 6129301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.